Medication use and adherence among elderly medicare beneficiaries with diabetes enrolled in part D and retiree health plans

Medical Care

Volumn 49, Issue 5, 2011, Pages 511-515

  Stuart, Bruce ^a   Simoni Wastila, Linda ^a   Yin, Xianghua ^a   Davidoff, Amy ^a   Zuckerman, Ilene H ^a   Doshi, Jalpa ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

diabetes; drug adherence; Medicare Part D; retiree drug coverage

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT;

AGED; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; PENSIONS; PROPENSITY SCORE; UNITED STATES;

EID: 79954963074     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31820bf885     Document Type: Article

References (30)

1. Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy. Washington, DC: MedPAC; 2010.
2. Davidoff A, Stuart B, Shoemaker JS, et al. Medicare Part D enrollment of previously uninsured Medicare beneficiaries. Health Affairs. 2010;29:1255-1263.
3. Coulson N, Stuart B. Persistence in the use of pharmaceuticals by the elderly: evidence from annual claims. J Health Econ. 1992;11: 315-328.
4. Stuart B. How Disease Burden Influences Medication Patterns for Medicare Beneficiaries: Implications for Policy. New York: The Commonwealth Fund; 2008.
5. Sun SX, Lee KY, Aruru M. Examining Part D beneficiaries' medication use in the doughnut hole. Am J Pharm Benefit. 2009;1:19-28.
6. Raebel MA, Delate T, Ellis JL, et al. Effects of reaching the drug benefit threshold on Medicare Members' Healthcare utilization during the first year of Medicare Part D. Med Care. 2008;46:1116-1122.
7. Hoadley J, Hargrave E, Cubanski J, et al. The Medicare Part D Coverage Gap: Cost and Consequences 2007. Menlo Park CA: The Henry J. Kaiser Family Foundation; 2008
8. Yin W, Basu A, Zhang A, et al. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. An of Int Med. 2008;148:169-177. (Pubitemid 351665504)
9. Zhang J, Yin W, Sun S, et al. The impact of the Medicare Part D prescription benefit on generic drug use. J Gen InternMed. 2008;23:1673-1678.
10. Zhang J, Yin W, Sun S, et al. The effect of Medicare Part D on drug and medical spending. N Eng J Med. 2009;361:52-61.
11. Ketcham J, Simon K. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care. 2008;14(11 Spec No.):Sp14-SP22.
12. Lichtenberg FR, Sun S. The impact of Medicare Part D on prescription drug use by the elderly. Health Affairs. 2007;26:1735-1744.
13. Pedan A, Lu J, Varasteh L. Assessment of drug consumption patterns for Medicare Part D patients. Am J Manag Care. 2009;15:323-327.
14. Schneeweiss S, Patrick A, Pesdan A, et al. The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Affairs Web Exclusive. 2009;28:w305-w316.
15. Safran D, Strollo MK, Gutterman S, et al. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study. J Gen Intern Med. 2009;25:10-17.
16. Buccaneer. Chronic Condition Warehouse User Manual. 2009. Available at http://ccwdata.org/downloads/CCW%20User%20Manual. pdf. Accessed December 15, 2009.
17. Adamson D, Chang S, Hansen L. Heath Research Data for the Real World: The MarketScan Databases. New York, NY: Thomson Healthcare; 2008.
18. Stuart B, Simoni-Wastila L, Zuckerman I, et al. Chartbook of Medication Use by Aged and Disabled Medicare Beneficiaries across the Spectrum of Morbidity, Baltimore: The Peter Lamy Center on Drug Therapy and Aging; 2007.
19. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2008;31(suppl 1):S12-S54.
20. Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes: guidelines for improving the care of the older person with diabetes mellitus. JAGS. 2003;51:S265-S280.
21. Rosen AB, Hamel MB, Weinstein MC, et al. Cost-weffectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005;143:89-99.
22. Kamari Y, Shaish A, Bitzur R, et al. Should all diabetic patients be treated with statins? Diabetes Care. 2009;32(suppl 2):S378-S383.
23. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
24. Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension, and dyslipidaemia: a review. Int J Clin Pract. 2008;62:76-87. (Pubitemid 350294021)
25. Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. Santa Monica, CA: RAND Corp; 2009.
26. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques, 2001. SAS Institute, Cary NC:214-26
27. Stuart BC, Lloyd JT, Simoni-Wastila L, et al. Increased persistency in medication use by US Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32:647-649.
28. Rosan AB. Should all individuals with diabetes be treated with an ACEinhibitor? Are they? J Gen Intern Med. 2004;19(suppl 1):211.
29. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218-1224. (Pubitemid 38579798)
30. Salas M, Hughes D, Zuluaga A, et al. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value in Health. 2009;12:915-922.